Veronica Barros possesses a robust background in pharmaceutical sciences, with experience spanning scientific initiation in organic synthesis at FAPESP focused on developing inhibitors for monoamine oxidase B to address Parkinson's disease, and roles in medical information at Eli Lilly and Company and PPD. At Eli Lilly, Veronica engaged in delivering evidence-based responses to healthcare professionals and conducting training for new hires. At PPD, responsibilities included compliance in medical communication, supporting pharmacovigilance, and providing balanced information to facilitate clinical decision-making. Education includes a Bachelor's degree in Pharmacy from Unifesp (2016-2021) and ongoing studies for a Master's degree in Pharmaceutical Sciences at Unifesp (2024-2026).
This person is not in the org chart
This person is not in any teams
This person is not in any offices